Product

KN056

Aliases

KN056 (0.1mg), KN056 (0.3mg), KN056 (1.0mg), KN056 (12.0mg), KN056 (18.0mg) (2 other aliases)

1 clinical trial

1 indication

Indication

Type 2 Diabetes

Clinical trial

A Randomized, Double-blind and Placebo-controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN056 in Healthy Participants

Status: Recruiting, Estimated PCD: 2023-12-22